Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $15
Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $19
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Raises Target Price to $18
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $25
A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $18 to $32
SI-BONE Price Target Maintained With a $19.00/Share by Needham
SI-BONE Analyst Ratings
SI-Bone's Strong Sales Growth and Innovative Product Pipeline Support Continued Buy Rating
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $16
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $16
SI-BONE Analyst Ratings
Truist Lowers Price Target on SI-BONE to $16 From $18, Keeps Buy Rating
Piper Sandler Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $19
Buy Rating Justified: SI-Bone's Growth Potential and Market Expansion Opportunities
Morgan Stanley Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $19
Analyst Ratings For SI-BONE
A Quick Look at Today's Ratings for Si-Bone(SIBN.US), With a Forecast Between $18 to $32
Truist Financial Remains a Buy on SI-Bone (SIBN)
Needham Maintains Buy on SI-BONE, Lowers Price Target to $19